David G. Genecov
Fondateur chez Dialectic Therapeutics, Inc.
Profil
David G.
Genecov was the founder of Novartis Gene Therapies, Inc. (2010) and Dialectic Therapeutics, Inc. (2018), where he held the title of President, Chief Executive Officer & Director.
He is also the founder of Cessation Therapeutics, LLC.
Currently, he holds the position of Director at Cersci Therapeutics, Inc. In the past, he worked as the Managing Director at BioLife Cell Bank Dallas LLC.
Postes actifs de David G. Genecov
| Sociétés | Poste | Début |
|---|---|---|
Dialectic Therapeutics, Inc.
 Dialectic Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Dialectic Therapeutics, Inc. operates as a pre-clinical biotechnology company. It develops anti-cancer drugs. The company was founded by David G. Genecov and John D. Harkey Jr. in 2018 and is headquartered in Dallas, TX. | Fondateur | 01/01/2018 |
Cersci Therapeutics, Inc.
 Cersci Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cersci Therapeutics, Inc. operates as pharmaceutical company. The firm develops non-opioid analgesic drug products without the deleterious side effects. The company was founded by Lucas Rodriguez and Brent Duncan in 2019 and is headquartered in Dallas, TX. | Directeur/Membre du Conseil | - |
Cessation Therapeutics, LLC
 Cessation Therapeutics, LLC Pharmaceuticals: MajorHealth Technology Cessation Therapeutics, LLC is a clinical-stage pharmaceutical company that develops immunobiologics to prevent and protect against overdose. The company is based in San Jose, CA. The company's monoclonal antibodies are designed to target fentanyl and future synthetic opioids and other substances. The company has the potential to treat a range of substance use disorders and improve the lives of patients and families affected by the addiction crisis. Cessation was founded in 2018 by Mark Pearson and John D. Harkey, Jr., experienced, successful long-term biotech investors. The CEO is Mark E. Pearson. | Fondateur | - |
Anciens postes connus de David G. Genecov
| Sociétés | Poste | Fin |
|---|---|---|
| AVEXIS INC | Fondateur | - |
BioLife Cell Bank Dallas LLC
 BioLife Cell Bank Dallas LLC Medical/Nursing ServicesHealth Services BioLife Cell Bank Dallas LLC operates as a tissue and stem cell bank. The company was founded on February 6, 2012 and is headquartered in Dallas, TX. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
BioLife Cell Bank Dallas LLC
BioLife Cell Bank Dallas LLC Medical/Nursing ServicesHealth Services BioLife Cell Bank Dallas LLC operates as a tissue and stem cell bank. The company was founded on February 6, 2012 and is headquartered in Dallas, TX. | Health Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Dialectic Therapeutics, Inc.
Dialectic Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Dialectic Therapeutics, Inc. operates as a pre-clinical biotechnology company. It develops anti-cancer drugs. The company was founded by David G. Genecov and John D. Harkey Jr. in 2018 and is headquartered in Dallas, TX. | Commercial Services |
Cersci Therapeutics, Inc.
Cersci Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cersci Therapeutics, Inc. operates as pharmaceutical company. The firm develops non-opioid analgesic drug products without the deleterious side effects. The company was founded by Lucas Rodriguez and Brent Duncan in 2019 and is headquartered in Dallas, TX. | Health Technology |
Cessation Therapeutics, LLC
Cessation Therapeutics, LLC Pharmaceuticals: MajorHealth Technology Cessation Therapeutics, LLC is a clinical-stage pharmaceutical company that develops immunobiologics to prevent and protect against overdose. The company is based in San Jose, CA. The company's monoclonal antibodies are designed to target fentanyl and future synthetic opioids and other substances. The company has the potential to treat a range of substance use disorders and improve the lives of patients and families affected by the addiction crisis. Cessation was founded in 2018 by Mark Pearson and John D. Harkey, Jr., experienced, successful long-term biotech investors. The CEO is Mark E. Pearson. | Health Technology |